Tuesday, March 29, 2011 | 1:00 PM - 5:00 PM
The New York Academy of Sciences
According to the American Blood Center, approximately 14 million units of blood are transfused in the United States every year. Current screening protocols routinely test for several pathogens, including the Hepatitis B virus, Hepatitis C virus, Human Immunodeficiency viruses, Types 1 and 2, Human T-Lymphotropic virus Types 1 and 2 and syphilis.
Recent headlines indicate that the blood supply may contain other organisms, such as Xenotropic Murine Leukemia Virus Related Virus (XMRV), that are not currently being identified in these routine screens.
This symposium will diagnose the current problems, reveal recent advances in the testing and screening of the blood supply, and will explore future directions.
W. Ian Lipkin, MD
Judy A. Mikovits, PhD
Whittemore Peterson Institute for Neuro-Immune Disease
Gail Moskowitz, MD